Viking Therapeutics (VKTX) News Today $42.25 +0.76 (+1.83%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?December 21 at 6:26 AM | fool.comMy Top 10 Stocks to Buy for 2025December 21 at 4:05 AM | fool.comViking Therapeutics' (VKTX) Buy Rating Reiterated at HC WainwrightDecember 21 at 3:17 AM | americanbankingnews.comB.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)December 20 at 9:43 PM | markets.businessinsider.comWhy Viking Therapeutics Tumbled by More Than 10% This WeekDecember 20 at 6:32 PM | fool.comViking Therapeutics (NASDAQ:VKTX) Shares Up 4.8% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Trading Up 4.8% - Should You Buy?December 20 at 2:13 PM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Up - Time to Buy?Viking Therapeutics (NASDAQ:VKTX) Shares Gap Up - Still a Buy?December 20 at 10:37 AM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 7.2% - Time to Buy?Viking Therapeutics (NASDAQ:VKTX) Shares Up 7.2% - Should You Buy?December 19 at 2:52 PM | marketbeat.comCompanies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In GrowthDecember 19 at 12:13 PM | finance.yahoo.comViking Therapeutics: Competition Fears Are ExaggeratedDecember 19 at 12:13 PM | seekingalpha.comMML Investors Services LLC Has $1.29 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)MML Investors Services LLC grew its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 193.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,352 shares of the biotechnology company's stock aDecember 19 at 4:09 AM | marketbeat.comXTX Topco Ltd Lowers Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)XTX Topco Ltd reduced its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 91.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,122 shares of the biotechnology company's stock after sellinDecember 19 at 3:52 AM | marketbeat.comViking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone ElseDecember 18 at 9:11 PM | yahoo.comWhat's Going On With Viking Therapeutics Stock On Wednesday?December 18 at 4:10 PM | finance.yahoo.comWhy Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today?December 18 at 4:10 PM | msn.comViking Therapeutics (NASDAQ:VKTX) Trading Down 8.9% - Should You Sell?Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 8.9% - Should You Sell?December 18 at 3:33 PM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Down - What's Next?Viking Therapeutics (NASDAQ:VKTX) Shares Gap Down - Time to Sell?December 18 at 1:08 PM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $102.00 price objective on shares of Viking Therapeutics in a research report on Wednesday.December 18 at 10:23 AM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 0.6% - Here's What HappenedViking Therapeutics (NASDAQ:VKTX) Trading 0.6% Higher - Still a Buy?December 17, 2024 | marketbeat.comIs Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds?December 17, 2024 | insidermonkey.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 2% - Should You Buy?Viking Therapeutics (NASDAQ:VKTX) Shares Up 2% - Here's What HappenedDecember 16, 2024 | marketbeat.comPrediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030December 16, 2024 | fool.comViking Therapeutics, Inc. (NASDAQ:VKTX) Receives $106.75 Consensus PT from AnalystsDecember 16, 2024 | americanbankingnews.com2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall StreetDecember 15, 2024 | fool.comViking Therapeutics (NASDAQ:VKTX) Trading Down 2.4% - What's Next?Viking Therapeutics (NASDAQ:VKTX) Trading Down 2.4% - Time to Sell?December 13, 2024 | marketbeat.comVestcor Inc Takes $741,000 Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Vestcor Inc bought a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm bought 11,700 shares of the biotechnology company's stock, valued at approximately $741,000. Several other hDecember 13, 2024 | marketbeat.comStifel Financial Corp Acquires 62,956 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Stifel Financial Corp raised its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 92.1% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 131,348 shares of the biotechnology company's stock after buyingDecember 13, 2024 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Rating of "Buy" from AnalystsShares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) have earned an average rating of "Buy" from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Eleven research analysts have rated the stock with a buy rating and two have given a strong buy raDecember 13, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.8% - What's Next?Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.8% - Should You Sell?December 12, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 0.6% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Stock Price Up 0.6% - Should You Buy?December 11, 2024 | marketbeat.comState Street Corp Sells 448,361 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)State Street Corp lessened its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 8.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,674,067 shares of the biotechnology company's stock after selling 448December 11, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 2.7% - Time to Sell?Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.7% - Time to Sell?December 10, 2024 | marketbeat.comWarning: This Skyrocketing Stock Has a Hidden RiskDecember 10, 2024 | fool.comViking Therapeutics (NASDAQ:VKTX) Shares Up 1.8% - Still a Buy?Viking Therapeutics (NASDAQ:VKTX) Shares Up 1.8% - Time to Buy?December 9, 2024 | marketbeat.com2 'Strong Buy' Biotech Stocks With 120% or More Upside PotentialDecember 8, 2024 | msn.comPier Capital LLC Has $5.64 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Pier Capital LLC boosted its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 55.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 89,147 shares of the biotechnology company's stock after purchasDecember 8, 2024 | marketbeat.comIHT Wealth Management LLC Takes Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)IHT Wealth Management LLC purchased a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 13,348 shares of the biotechnology coDecember 7, 2024 | marketbeat.comRockefeller Capital Management L.P. Raises Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Rockefeller Capital Management L.P. increased its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 109.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,023 shares of the biotechnology comDecember 7, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading 3.2% Higher - What's Next?Viking Therapeutics (NASDAQ:VKTX) Trading 3.2% Higher - Still a Buy?December 6, 2024 | marketbeat.comPromising Prospects for Viking Therapeutics’ VK2735 in Obesity Treatment: A Buy Rating with $125 Price TargetDecember 6, 2024 | markets.businessinsider.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by Bank of Montreal CanBank of Montreal Can increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 548.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 35,252 shares of the biotechnology company's stock aftDecember 6, 2024 | marketbeat.comCerity Partners LLC Takes Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Cerity Partners LLC purchased a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,969 shares of the biotechnologDecember 6, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.9% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Shares Up 1.9% - Here's WhyDecember 5, 2024 | marketbeat.comSphera Funds Management LTD. Makes New Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Sphera Funds Management LTD. acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 133,066 shares of the biotechnology company's stock, valueDecember 5, 2024 | marketbeat.comShould You Forget Pfizer and Buy These Unstoppable Stocks Instead?December 5, 2024 | fool.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 1% - Should You Sell?Viking Therapeutics (NASDAQ:VKTX) Shares Down 1% - Time to Sell?December 4, 2024 | marketbeat.comPortolan Capital Management LLC Acquires 46,340 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Portolan Capital Management LLC increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 58.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,762 shares of theDecember 4, 2024 | marketbeat.comMelqart Asset Management UK Ltd Has $5.96 Million Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX)Melqart Asset Management UK Ltd reduced its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 18.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 94,107 shares of the biotechnology company's stock after selling 20,840December 4, 2024 | marketbeat.comBNP Paribas Financial Markets Lowers Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)BNP Paribas Financial Markets reduced its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 66.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,712 shares of the biotechnoDecember 4, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTXDecember 3, 2024 | prnewswire.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.320.61▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼2516▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Teva Pharmaceutical Industries News Today BeiGene News Today Moderna News Today Viatris News Today Summit Therapeutics News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Sarepta Therapeutics News Today Catalent News Today Vaxcyte News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
